Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 8/20 | 0.47 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | KHK | P50053 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17445647 | 0.90 | ENPP1 (0.42) | ENPP1ENPP3DCTPP1BACE1ALDH1A1 | |
| SCHEMBL12340181 | 0.89 | ENPP1 (0.40) | ENPP1ENPP3KDM4EMAPTDCTPP1 | |
| SCHEMBL20099325 | 0.88 | ENPP1 (0.41) | ENPP1ENPP3DCTPP1BACE1ALDH1A1 | |
| SCHEMBL9884490 | 0.79 | ENPP1 (0.33) | ENPP1ENPP3KDM4EMAPT | |
| SCHEMBL14280961 | 0.76 | ENPP1 (0.47) | ENPP1KDM4EMAPTALDH1A1GAA | |
| SCHEMBL28732554 | 0.76 | ENPP1 (0.44) | ENPP1ENPP3DCTPP1GAA | |
| SCHEMBL12355748 | 0.73 | MAPT (0.48) | KDM4EMAPTALDH1A1PKML3MBTL1 | |
| SCHEMBL14280971 | 0.72 | MAPT (0.39) | KDM4EMAPTALDH1A1GAAPKM | |
| SCHEMBL13641617 | 0.72 | MAPT (0.63) | KDM4EMAPTALDH1A1GAANPSR1 | |
| SCHEMBL30753427 | 0.72 | MAPT (0.63) | KDM4EMAPTALDH1A1GAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11678571-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2023-06-13 | — | — | US | disclosed |
| US-20210376247-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-12-02 | — | — | US | disclosed |
| US-11152574-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2021-10-19 | — | — | US | disclosed |
| US-11094888-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2021-08-17 | — | — | US | disclosed |
| US-20210083194-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-03-18 | — | — | US | disclosed |
| US-10283717-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2019-05-07 | — | — | US | disclosed |
| US-10263192-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2019-04-16 | — | — | US | disclosed |
| US-20180090685-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
| US-20180040828-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20080014464-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20080014464-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11152574-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | RPL21, RPS21, AOC2 | ENPP1 1606/4885ENPP3 2398/4885KDM4E 1889/4885 |
| US-11678571-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | RPS17, RPS19, CDK17 | ENPP1 4192/4885ENPP3 2625/4885KDM4E 502/4885 |
| US-20210083194-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | RPL21, RPS21, AOC2 | ENPP1 1606/4885ENPP3 2398/4885KDM4E 1889/4885 |
| US-20180090685-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | SLC18A1, SLC18A2, AOC2 | ENPP1 2242/4885ENPP3 2235/4885KDM4E 2498/4885 |
| US-10283717-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | SLC18A1, SLC18A2, AOC2 | ENPP1 2242/4885ENPP3 2235/4885KDM4E 2498/4885 |
| US-11094888-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | SLC18A1, SLC18A2, AOC2 | ENPP1 2242/4885ENPP3 2235/4885KDM4E 2498/4885 |
| US-10263192-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | SLC18A1, SLC18A2, AOC2 | ENPP1 2242/4885ENPP3 2235/4885KDM4E 2498/4885 |
| US-20180040828-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | SLC18A1, SLC18A2, AOC2 | ENPP1 2242/4885ENPP3 2235/4885KDM4E 2498/4885 |
| US-20210376247-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | RPS17, RPS19, CDK17 | ENPP1 4192/4885ENPP3 2625/4885KDM4E 502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.